CSIMarket Company Name, Ticker, Competitors, else..
 


• Quick Ratio
• Working Capital
• LT Debt to Equity
• Debt to Equity
• Leverage Ratio
• Tangible Leverage
• Interest Coverage
• Debt Coverage
• Work. Cap. Per Revenue
The Greater Cannabis Company Inc   (GCAN)
Other Ticker:  
 

Cumulative The Greater Cannabis Inc 's Quick Ratio for Trailing Twelve Months Period

GCAN's Quick Ratio for Trailing Twelve Months Period and Cash & cash equivalent, Current Liabilities growth


Select the Comparisons : Select the Ratio:

GCAN Quick Ratio for Trailing Twelve Months Period

 (Jun 30 2023)
II. Quarter		 (Mar 31 2023)
I. Quarter		 (Dec 31 2022)
IV. Quarter		 (Sep 30 2022)
III. Quarter		 (Jun 30 2022)
II. Quarter
Y / Y Current Liabilities Growth -18.99 % -26.55 % 0.03 % 37.72 % 52.9 %
Y / Y Cash & cash equivalent Growth -22.64 % -31.57 % -40.83 % -45.34 % -1.74 %
Quick Ratio for Trailing Twelve Months Period 0.48 0.48 0.49 0.56 0.7
Total Ranking # # # # # 2786
Seq. Current Liabilities Growth 5.41 % 3.78 % -7.45 % -19.99 % -4.43 %
Seq. Cash & cash equivalent Growth -4.3 % -6.84 % -6.59 % -7.1 % -15.34 %

GCAN Segments >> Back to GCAN Financial Strength Comparisons >> Compare GCAN Quick Ratio to its Competitors

Quick Ratio for Trailing Twelve Months Period Comment for 12 Months ending at Jun 30 2023
On the trailing twelve months basis Despite year on year decrease in The Greater Cannabis Inc 's average Current Liabilities to $1 millions, Quick Ratio for Trailing Twelve Months Period to 0.48 below company average Quick Ratio for Trailing Twelve Months Period.
Quick Ratio for Trailing Twelve Months Period is the average cumulative value over the last four quarters.

Among companies operatig within Major Pharmaceutical Preparations industry 455 other companies have achieved higher Quick Ratio for Trailing Twelve Months Period than The Greater Cannabis Inc . While overall ranking remained unchanged compare to previous quarter at no. .

What is Quick Ratio?
Learn more about GCAN
Quick Ratio GCAN in the most recent quarter
Quick Ratio for Trailing Twelve Months Period Company Ranking
Within: No.
Industry # 456
Sector # 878
S&P 500 # 2272


Quick Ratio for Trailing Twelve Months Period Statistics
High Average Low
0.89 0.36 0.08
(Sep 30 2021)   (Dec 31 2018)




Companies with similar average Quick Ratio for Trailing Twelve Months Period for 12 months ending Jun 30 2023, within Major Pharmaceutical Preparations Industry Quick Ratio for Trailing Twelve Months Period
Amphastar Pharmaceuticals Inc   1.30 
Evelo Biosciences Inc   1.29 
Biora Therapeutics Inc   1.29 
Rockwell Medical inc   1.28 
Nrx Pharmaceuticals Inc   1.27 
Puma Biotechnology Inc   1.26 
Impel Pharmaceuticals Inc   1.26 
Palatin Technologies Inc   1.25 
Timber Pharmaceuticals Inc   1.24 
Evotec Se  1.23 
Prophase Labs Inc   1.21 
Evolus Inc   1.21 
Dar Bioscience Inc   1.19 
Celyad Oncology Sa  1.19 
Effector Therapeutics Inc   1.19 
Jazz Pharmaceuticals Plc  1.19 
Kineta Inc   1.16 
Inflarx N v   1.15 
Apexigen Inc   1.11 
Nanobiotix S a   1.09 
Lucy Scientific Discovery Inc   1.07 
Intelgenx Technologies Corp   1.02 
Exicure Inc   1.01 
Sonoma Pharmaceuticals Inc   1.01 
Morphosys Ag  1.01 
Biofrontera Inc   0.99 
Scisparc Ltd   0.99 
Applied Therapeutics inc   0.97 
Contrafect Corporation  0.94 
Zoetis Inc   0.93 




Help

About us

Advertise
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com